Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 101-110 of 132 for

Edit search filters
  1. Improving Genetic Referral Rates in Women with Ovarian Cancer

    Rochester, MN

  2. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors

    Rochester, MN

  3. Broad Evidence of Systemic Immune Activation in Long Term Survivors of Advanced Ovarian Cancer

    Jacksonville, FL, Rochester, MN

  4. A Study to Evaluate the Venn Ovarian CAncer Liquid Biopsy

    Jacksonville, FL

  5. Chemotherapy Toxicity On Quality of Life in Older Patients with Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Use of Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy and Risk of Malignancy in Genetic Mutation Carriers

    Rochester, MN

  7. A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus

    Rochester, MN

  8. A Study to Evaluate Immune Response Changes to Ovarian Cancer During Chemotherapy

    Rochester, MN

  9. Patient Experience and Understanding of Genetic Testing in Ovarian Cancer

    Rochester, MN

  10. Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

    Rochester, MN

.

Mayo Clinic Footer